博雅生物(300294.SZ):2024年度淨利潤3.97億元 同比增長67.18%
格隆匯3月18日丨博雅生物(300294.SZ)公佈2024年年度報吿,2024年公司實現營業收入17.35億元,同比下降34.58%;歸屬於上市公司股東的淨利潤3.97億元,同比增長67.18%;歸屬於上市公司股東的扣除非經常性損益的淨利潤3.02億元,同比增長110.77%;基本每股收益0.79元。
公司經本次董事會審議通過的利潤分配預案為:以504,248,738股為基數,向全體股東每10股派發現金紅利1.60元(含税),送紅股0股(含税),以資本公積金向全體股東每10股轉增0股。同時,公司於2024年10月完成2024年半年度利潤分派,每10股派送現金1.60元(含税),共派送現金8067.98萬元(含税)。按2024年末總股本計算,則公司2024年度每10股合計派送現金3.20元(含税),年度派送現金紅利總額合計1.61億元(含税),佔2024年度公司實現歸屬於上市公司股東的淨利潤的40.65%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.